Vasodilator agents improve hemodialysis vascular access patency: A population-based study from Korea.

ABSTRACT:

Abstract

Vascular access (VA) failure is an important problem for patients undergoing hemodialysis, and maintaining VA patency is challenging. In this study, we used a nationwide database to investigate the effects of nitrate, as a vasodilator, on VA failure in hemodialysis patients.We investigated the Korean insurance claims data of hemodialysis patients who underwent angioplasty for VA failure between January 2012 and December 2017. The patients were divided into 2 groups: those not receiving vasodilator therapy (controls) and those receiving any vasodilator administration (vasodilator treatment, VDT). The primary endpoint was VA primary patency, defined as the time between arteriovenous dialysis access creation and the first percutaneous transluminal angioplasty (PTA).During the

SUBMITTER: Kim DH 

PROVIDER: S-EPMC8500602 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature